Products for Research Use Only
RegisterLogin

Inebilizumab

CAT: 0931-T76713-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T76713-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
1299440-37-1
Target
Immunology/Inflammation related, ADC Antibody
Related Pathways
Immunology/Inflammation, Antibody-drug Conjugate/ADC Related
Purity
0.993
Bioactivity
Inebilizumab is a humanized anti-CD19 monoclonal antibody with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab can be used to treat a range of autoimmune diseases associated with CD19 B cells, such as multiple sclerosis and optic neuromyelitis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Alternative Products

CatalogName
HY-P99113-01Inebilizumab
CBA1056-01Inebilizumab Biosimilar
GTR18337565-01Inebilizumab Antibody
591926Inebilizumab (CD19)
047739CD19 (inebilizumab) discontinued
DHD10802Research Grade Inebilizumab
A2564-1mgInebilizumab (Anti-CD19)
E55B0749Inebilizumab (Reference antibody)
HY-P99113A-01Inebilizumab (FUT8-KO)
ICH5168-10mgInebilizumab Biosimilar - Research Grade

Popular Products